Reviewed and Approved by Dr. Mehmet Yildiz

Curator’s Note: ALS is often explained through medical terms, survival numbers, and clinical language, but behind all of that is a very human story. This article was written to help ordinary people understand what the disease actually feels like, both physically and emotionally. It explores how ALS slowly affects movement, speech, breathing, memory, and daily life, while also revealing the quiet strength, fear, love, and dignity that many patients and families carry throughout the journey. The author wrote this with inspiration from a case study on ALS titled A Comprehensive Exploration of ALS Patterns After Years of Dedicated Research, published by Dr. Mehmet Yildiz on Medium.com in January 2024.

Introduction

Most people never think about how many invisible systems are working together just to lift a hand, swallow water, smile at someone, or take a breath without effort. The human nervous system performs thousands of silent calculations every second, carrying electrical signals between the brain, spinal cord, muscles, and organs with extraordinary precision. ALS begins destroying that communication system slowly, one motor neuron at a time.

At first, the changes may appear small. A person may stumble slightly while walking, struggle opening a bottle, notice muscle twitching under the skin, or hear subtle changes in their speech. These signs often feel harmless in the beginning. Over time, however, the disease reshapes nearly every physical function connected to voluntary movement.

Amyotrophic lateral sclerosis, commonly called ALS or motor neuron disease, is a rare neurodegenerative condition affecting the motor neurons responsible for controlling muscles. These neurons exist in both the brain and spinal cord. Upper motor neurons send movement instructions from the brain downward, while lower motor neurons carry those signals directly into muscles.

ALS damages both systems simultaneously. As neurons die, muscles stop receiving instructions properly. Weakness gradually becomes paralysis. Speech becomes difficult. Swallowing becomes dangerous. Breathing slowly becomes exhausting. The disease does not usually damage hearing, vision, touch, or awareness, which creates one of the hardest emotional realities of ALS, because many patients remain mentally aware while losing physical control over the body itself.

How ALS Usually Begins

ALS rarely arrives dramatically in the beginning. Early symptoms are often subtle enough to be mistaken for stress, aging, overwork, or minor injuries. Some people first notice weakness in one hand while writing or buttoning clothes. Others begin stumbling because of foot drop, where the foot drags slightly during walking.

Muscle twitching, stiffness, cramps, and reduced coordination are also common early signs. In bulbar-onset ALS, the first symptoms involve speech and swallowing, causing slurred speech, nasal voice changes, or difficulty chewing food. A smaller number of patients first experience breathing problems because the muscles supporting respiration weaken before limb symptoms appear.

The Nervous System Behind Movement

Every voluntary movement depends on a chain of communication inside the nervous system. Movement begins in the motor cortex of the brain, where upper motor neurons generate signals that travel down the spinal cord. These neurons connect to lower motor neurons, which carry instructions directly into muscles. When ALS damages upper motor neurons, muscles become stiff, rigid, and overactive.

Reflexes increase abnormally, causing spasticity and muscle tightness. When lower motor neurons degenerate, muscles weaken, shrink, and twitch beneath the skin in small movements called fasciculations. Classic ALS damages both systems simultaneously, which is why patients experience a combination of stiffness, weakness, muscle wasting, and progressive loss of movement over time.

Different Types of ALS

ALS does not look identical in every patient. Doctors classify the disease according to where symptoms begin and which neurons are primarily affected.

• Limb-onset ALS: The most common form of ALS. Symptoms usually begin with weakness in the arms or legs, causing difficulty walking, lifting objects, writing, or performing everyday physical tasks.
• Bulbar-onset ALS: Begins with speech and swallowing difficulties. People may notice slurred speech, chewing problems, or choking while eating. This form often progresses more aggressively than limb-onset ALS.
• Respiratory-onset ALS: A rarer form where breathing problems appear first. Patients may experience shortness of breath, fatigue, or difficulty breathing while lying down. It is usually associated with shorter survival.
• Primary Lateral Sclerosis (PLS): Mainly affects upper motor neurons, causing stiffness, muscle tightness, balance issues, and slowed movement.
• Progressive Muscular Atrophy (PMA): Mainly affects lower motor neurons, leading to muscle weakness, twitching, and visible muscle wasting.
• Regional Variants: Some rare forms remain limited to one body region for long periods before spreading further, which may result in slower progression and longer survival compared to classical ALS.

Why the Disease Progresses

ALS progression varies widely between individuals, but symptoms usually spread gradually into neighboring body regions. Weakness beginning in one arm may later affect the opposite arm or the leg on the same side. Bulbar-onset patients often develop arm weakness before leg involvement.

Over time, most individuals lose the ability to walk independently, use their hands normally, speak clearly, swallow safely, or breathe without assistance. Respiratory muscle weakness eventually becomes life-threatening because coughing and breathing grow increasingly difficult.

The body slowly loses its ability to perform automatic physical tasks people normally never notice. ALS transforms simple acts such as drinking water, standing up, turning in bed, or taking a deep breath into exhausting physical challenges.

Measuring Disease Progression

Doctors often track ALS using the ALS Functional Rating Scale-Revised, known as ALSFRS-R. This clinical tool measures daily functions including speech, swallowing, breathing, walking, writing, and physical independence. Scores range from forty-eight, representing normal function, down to zero, representing severe disability. On average, many patients lose around one point each month, although progression differs significantly from person to person.

Temporary periods of stability sometimes occur, especially when patients adapt physically or begin supportive therapies. However, long-term reversal of symptoms remains extremely rare. Researchers rely heavily on this scale during clinical trials because even small changes in progression speed may reveal whether experimental treatments are slowing neurological decline.

Cognitive and Emotional Changes

ALS does not only affect muscles. Around thirty to fifty percent of patients experience cognitive or behavioral changes during the disease. Problems with memory, language, decision-making, social understanding, and emotional control may gradually appear. Some patients develop pseudobulbar affect, a neurological symptom causing sudden laughing or crying unrelated to actual emotions.

These episodes can become socially painful because people nearby may misunderstand the reactions completely. Around ten to fifteen percent of patients eventually develop frontotemporal dementia, known as FTD, which can cause apathy, impulsive behavior, emotional detachment, repetitive actions, and personality changes. Scientists now view ALS and FTD as closely connected diseases sharing overlapping genetic and biological mechanisms.

Genetics and Hidden Inheritance

Most ALS cases are considered sporadic, meaning no obvious family history exists. However, researchers increasingly recognize that hidden genetic factors influence many supposedly non-inherited cases.

• Sporadic ALS: The most common form of ALS, where the disease appears without a clearly known inherited pattern.
• Familial ALS: Accounts for roughly 10–15% of cases and involves inherited genetic mutations passed through families.
• Major ALS Genes: Scientists have identified more than forty genes associated with ALS, although four major genes are responsible for a large percentage of known inherited cases:
  • C9orf72
  • SOD1
  • FUS
  • TARDBP
• C9orf72 Mutation: Especially important because it strongly links ALS with frontotemporal dementia (FTD), showing how movement disorders and cognitive decline can overlap neurologically.
• Modern Genetic Research: Scientists now believe ALS may exist along a broader neurological spectrum rather than as one single isolated disease. This has changed how researchers understand inheritance, progression, and brain involvement in ALS.

The Role of SOD1 and Toxic Proteins

One of the most studied ALS-related genes is SOD1, which helps produce an enzyme protecting cells from harmful reactive oxygen species. Healthy SOD1 activity helps maintain stable neuronal conditions. Mutations in the SOD1 gene interfere with these protective mechanisms and may trigger abnormal protein folding, inflammation, and motor neuron death.

Scientists now believe ALS involves toxic protein accumulation inside nerve cells. In most cases, abnormal TDP-43 protein aggregates appear within motor neurons. In SOD1 and FUS-related ALS, different proteins accumulate instead. Researchers suspect these misfolded proteins spread between cells in a prion-like pattern, gradually expanding neurological damage throughout the brain and spinal cord over time.

Environmental Factors and Long-Term Exposure

Genetics alone does not fully explain ALS. Researchers increasingly support a multi-step hypothesis where disease emerges through interactions between genetic vulnerability and environmental exposure across a lifetime. Factors most consistently linked with increased ALS risk include heavy metals such as lead and mercury, pesticides, industrial chemicals, smoking, electric shock, head injuries, and physically demanding occupations.

The influence of each individual exposure appears relatively small, but cumulative exposure over decades may gradually increase neurological stress. Agricultural workers, military personnel, professional athletes, and people exposed to repeated physical trauma sometimes experience overlapping risk factors that researchers continue studying carefully.

Viruses, Immunity, and Cellular Stress

ALS research has expanded far beyond simple nerve degeneration. Scientists now investigate immune dysfunction, viral remnants embedded in the human genome, and inflammatory activity inside the nervous system. Many ALS patients show unusually high activation of endogenous retroviruses, ancient viral sequences inherited from early human evolution.

Researchers also discovered abnormal immune responses involving inflammatory T cells targeting motor neurons directly. These findings suggest ALS may involve interactions between genetics, immunity, inflammation, protein dysfunction, and cellular stress simultaneously. Instead of one single pathway causing the disease, ALS appears to emerge from multiple biological systems gradually failing together under accumulated neurological pressure.

How ALS Is Diagnosed

There is currently no single test capable of definitively diagnosing ALS. Doctors usually diagnose the disease through clinical evaluation, neurological examination, and elimination of other possible conditions. Electromyography, known as EMG, measures electrical activity inside muscles and helps identify patterns of motor neuron damage.

MRI scans may help rule out spinal tumors, multiple sclerosis, herniated discs, or other neurological disorders causing similar symptoms. Blood tests, nerve conduction studies, muscle biopsies, and additional laboratory investigations are often performed to exclude ALS mimic syndromes. Diagnosis remains emotionally difficult because symptoms overlap with many other diseases, and patients often spend months or even years searching for clear answers before receiving confirmation.

Treatment and Disease Management

There is currently no cure capable of stopping or reversing ALS. Modern treatment mainly focuses on slowing progression, reducing symptoms, maintaining comfort, and extending quality of life. Riluzole modestly prolongs survival by reducing glutamate activity linked to neuronal overstimulation. Edaravone may help slow functional decline in certain patients by reducing oxidative stress.

A newer therapy called tofersen specifically targets SOD1-associated ALS using antisense genetic technology. Although these treatments cannot cure the disease, they represent important scientific progress toward precision-based neurological therapies. Supportive care remains equally important because maintaining nutrition, breathing function, communication ability, and emotional support dramatically influences daily quality of life.

Breathing Support and Survival

Respiratory failure is the leading cause of death in ALS. Non-invasive ventilation, often delivered through a mask connected to a ventilator, helps support weakened breathing muscles and can improve both survival and quality of life. Initially, breathing problems often appear during sleep, causing interrupted rest, headaches, fatigue, poor concentration, and morning confusion.

As respiratory muscles weaken further, shortness of breath develops during speaking, movement, or resting. Invasive ventilation through tracheostomy may prolong survival significantly, although it does not stop disease progression. Some patients eventually develop locked-in syndrome, where awareness remains intact despite near-complete paralysis. Even in advanced stages, many patients still report meaningful quality of life when supported by effective communication tools and compassionate care.

Communication, Therapy, and Daily Life

Physical therapy, occupational therapy, and speech therapy play major roles in helping people with ALS maintain independence for as long as possible. Low-impact exercise, stretching, mobility devices, wheelchairs, and adaptive equipment can improve comfort and preserve function.

Speech-language specialists teach communication techniques and eventually introduce assistive technologies such as voice-generating devices, eye-tracking systems, alphabet boards, and laser pointer communication tools. Many patients continue communicating effectively through eye movement long after speech becomes impossible.

These technologies do not erase the disease, but they protect something deeply human, the ability to express thought, emotion, humor, memory, and connection even while physical movement disappears.

Nutrition and Swallowing Challenges

Difficulty swallowing, known as dysphagia, affects most ALS patients at some stage of the disease. Eating gradually becomes exhausting and dangerous because weakened swallowing muscles increase the risk of choking or food entering the lungs. Many people begin losing weight rapidly due to muscle wasting and reduced calorie intake.

Doctors often recommend softer foods, thickened liquids, nutritional supplements, and swallowing strategies during earlier stages. When weight loss becomes severe or swallowing becomes unsafe, feeding tubes may be inserted directly into the stomach through procedures such as PEG or RIG. Maintaining nutrition significantly improves both survival and quality of life throughout disease progression.

Palliative Care and End-of-Life Decisions

Palliative care should begin early after diagnosis, not only during the final stages of illness. These discussions help patients and families understand future decisions involving ventilation, feeding tubes, emergency interventions, and end-of-life wishes. Many patients fear suffocation, although sudden choking death is actually uncommon in ALS.

Hospice care focuses on comfort, emotional support, pain relief, breathing management, and dignity during advanced disease. Opioids can reduce pain and breathlessness, while anxiety may be treated with supportive medications and counseling. One of the most important aspects of ALS care is preserving the patient’s sense of control, identity, and emotional connection even while physical independence slowly fades away.

The Global Impact of ALS

ALS remains a relatively rare disease, but its global impact continues growing as populations age worldwide. Researchers estimate that hundreds of thousands of people currently live with ALS globally, with cases expected to rise significantly in coming decades. The disease affects people of every race and nationality, although prevalence differs between regions and genetic backgrounds.

Certain geographic clusters, including Guam and parts of Japan, historically experienced dramatically higher ALS rates for reasons that still remain uncertain. Most epidemiological research has focused on Europe and North America, leaving many regions underrepresented scientifically. Better global awareness, earlier diagnosis, expanded research funding, and improved access to multidisciplinary care remain critical challenges for the future.

What ALS Reveals About Human Life

ALS forces people to confront uncomfortable truths modern life often avoids. Human beings spend years building identity around productivity, physical independence, achievement, speed, and control. ALS slowly removes many of those abilities while leaving awareness intact. It reveals how much human dignity exists beyond physical strength alone.

Many patients continue expressing love, humor, intelligence, faith, memory, and emotional depth long after movement disappears. Families caring for ALS patients often discover forms of patience, tenderness, loyalty, and emotional resilience they never imagined possible before illness entered their lives. The disease is medically devastating, but it also exposes something deeply human about vulnerability, dependence, compassion, and the fragile relationship between the body and the self.

Ref: https://www.ncbi.nlm.nih.gov/books/NBK556151